Defective dystrophic thymus determines degenerative changes in skeletal muscle.
Farini A
Nat Commun. 2021 Apr 8;12(1):2099. doi: 10.1038/s41467-021-22305-x
Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin-deficient mice.
Farini A
EMBO Mol Med. 2022 Dec 19;15(3):e16244. doi: 10.15252/emmm.202216244
Cellular Senescence in Immunity against Infections.
Marrella V, Facoetti A, Cassani B
Int J Mol Sci. 2022 Oct 6;23(19)doi: 10.3390/ijms231911845
APJ acts as a dual receptor in cardiac hypertrophy.
Scimia MC
Nature. 488(7411):394-8. doi: 10.1038/nature11263
The circulating level of FABP3 is an indirect biomarker of microRNA-1.
Varrone F
J Am Coll Cardiol. 2012 Nov 7;61(1):88-95. doi: 10.1016/j.jacc.2012.08.1003
Atrogin-1 deficiency promotes cardiomyopathy and premature death via impaired autophagy.
Zaglia T
J Clin Invest. 2014 May 1;124(6):2410-24. doi: 10.1172/JCI66339
Neutrophils promote Alzheimer’s disease-like pathology and cognitive decline via LFA-1 integrin.
Zenaro E
Nat Med. 2015 Jul 27;21(8):880-6. doi: 10.1038/nm.3913
Bioinspired negatively charged calcium phosphate nanocarriers for cardiac delivery of MicroRNAs.
Di Mauro V
Nanomedicine (Lond). 2016 Mar 16;11(8):891-906. doi: 10.2217/nnm.16.26
Peptidomimetic Targeting of Cavβ2 Overcomes Dysregulation of the L-Type Calcium Channel Density and Recovers Cardiac Function.
Rusconi F
Circulation. 2016 Aug 2;134(7):534-46. doi: 10.1161/CIRCULATIONAHA.116.021347
Content of mitochondrial calcium uniporter (MCU) in cardiomyocytes is regulated by microRNA-1 in physiologic and pathologic hypertrophy.
Zaglia T
Proc Natl Acad Sci U S A. 2017 Oct 9;114(43):E9006-E9015. doi: 10.1073/pnas.1708772114